Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Update to v3.0.2 (replacing v3.0.1). Removed the 'Back to Top' link, a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T21:39:22.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.2%
    Check dated 2025-09-07T18:06:03.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical topics such as plasma cell myeloma and hemic and lymphatic diseases. Notably, the drug daratumumab has been added, indicating a focus on specific treatments.
    Difference
    2%
    Check dated 2025-08-31T12:20:50.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:40:38.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:32:58.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T18:54:26.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.